Santen Pharmaceutical Co Ltd 2022 ESG Data Book
The report presents FY2022 group Scope 1 emissions of 16,948 t-CO2, location-based Scope 2 emissions of 21,390 t-CO2, and a Scope 3 total of 133,451 t-CO2. It reports 746,317 GJ of energy usage and 36,232 Mwh of renewable energy. The group had 4,144 employees, while the two listed operational-site fatality rows each show zero; the data received limited assurance from KPMG AZSA Sustainability Co., Ltd.
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: ESG Data Book
Pages: 18
Santen Pharmaceutical Co Ltd
The report presents FY2022 group Scope 1 emissions of 16,948 t-CO2, location-based Scope 2 emissions of 21,390 t-CO2, and a Scope 3 total of 133,451 t-CO2. It reports 746,317 GJ of energy usage and 36,232 Mwh of renewable energy. The group had 4,144 employees, while the two listed operational-site fatality rows each show zero; the data received limited assurance from KPMG AZSA Sustainability Co., Ltd.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Type
ESG Data Book
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees